MASSDEVICE ON CALL — Healthcare giant Abbott (NYSE:ABT) will officially split into 2 parts starting tomorrow, essentially separating the proprietary drug division from the rest of the company.
Ventlab Corp.
Recall: Ventlab pulls more than 14k defective manual respirators
Respiratory devices company Ventlab Corp. announced a nationwide recall of thousands of its manual resuscitators over concerns that the devices may not delivery enough or any air or oxygen to patients
The recall, which the company initially launched in July, affects more than 14,600 units across 12 different products, including the company’s RescueMed Infant Resuscitator and Premium Small Child Resuscitator, according to a press release.